SUMO3, Recombinant, Human (Small Ubiquitin-related Modifier 3, SUMO-3, SMT3 Homolog 1, SUMO-2, Ubiquitin-like Protein SMT3A, SMT3A, SMT3H1)
Catalog No : USB-S8026-20E
508.06€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | SUMO3, Recombinant, Human (Small Ubiquitin-related Modifier 3, SUMO-3, SMT3 Homolog 1, SUMO-2, Ubiquitin-like Protein SMT3A, SMT3A, SMT3H1) | ||
|---|---|---|---|
| Catalog No | USB-S8026-20E | ||
| Supplier’s Catalog No | S8026-20E | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E.coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 12.6 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (SDS-PAGE). | ||
| Form | Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 20% glycerol, 0.1M sodium chloride, 1mM DTT. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (SDS-PAGE). | ||
| Description | SUMO3, also known as small ubiquitin-related modifier 3, is a member of the SUMO protein family and functions in a manner similar to ubiquitin. However, unlike ubiquitin which targets proteins for degradation, SUMO3 protein participates in a number of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It regulates amyloid beta generation and may be critical in the onset or progression of Alzheimer’s disease. Source: Recombinant corresponding to aa1-92 of human SUMO3 protein, fused to His-tag at N-terminus, expressed in E.coli. AA Sequence: MGSSHHHHHH SSGLVPRGSH MSEEKPKEGV KTENDHINLK VAGQDGSVVQ FKIKRHTPLS KLMKAYCERQ GLSMRQIRFR FDGQPINETD TPAQLEMEDE DTIDVFQQQT GG Molecular Weight: 12.6kD (112aa) confirmed by MALDI-TOF Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
© 2020 Imugex All Rights Reserved